Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital.

Autor: Paulino Pereira LJ; Department of Urology, St Antonius Hospital, 3435CM Nieuwegein, The Netherlands., Reesink DJ; Department of Urology, St Antonius Hospital, 3435CM Nieuwegein, The Netherlands., de Bruin P; Department of Urology, St Antonius Hospital, 3435CM Nieuwegein, The Netherlands., Gandaglia G; Unit of Urology, Division of Oncology, Gianfranco Soldera Prostate Cancer Laboratory, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., van der Hoeven EJRJ; Department of Urology, St Antonius Hospital, 3435CM Nieuwegein, The Netherlands., Marra G; Department of Urology, Città della Salute e della Scienza, University of Turin, 10124 Turin, Italy., Prinsen A; Department of Urology, St Antonius Hospital, 3435CM Nieuwegein, The Netherlands., Rajwa P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.; Department of Urology, Medical University of Silesia, 41-800 Zabrze, Poland., Soeterik T; Department of Urology, St Antonius Hospital, 3435CM Nieuwegein, The Netherlands., Kasivisvanathan V; Division of Surgery and Interventional Science, University College London, London WC1E 6BT, UK., Wever L; Department of Urology, St Antonius Hospital, 3435CM Nieuwegein, The Netherlands., Zattoni F; Urologic Unit, Department of Surgery, Oncology and Gastroenterology, University of Padova, 35122 Padua, Italy., van Melick HHE; Department of Urology, St Antonius Hospital, 3435CM Nieuwegein, The Netherlands., van den Bergh RCN; Department of Urology, St Antonius Hospital, 3435CM Nieuwegein, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2023 Sep 29; Vol. 15 (19). Date of Electronic Publication: 2023 Sep 29.

Hospital variation in treatment patterns and oncological outcomes for patients with muscle-invasive and metastatic bladder cancer in the Netherlands.

Autor: Reesink DJ; Department of Urology, St. Antonius Hospital, Koekoekslaan 1, 3435 CM, Nieuwegein, The Netherlands. d.reesink@antoniusziekenhuis.nl., van de Garde EMW; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein / Utrecht, The Netherlands.; Division Pharmaco Epidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands., van der Nat P; Division Value Based Healthcare, St. Antonius Hospital, Nieuwegein / Utrecht, The Netherlands.; Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud UMC, Nijmegen, The Netherlands., Somford DM; Department of Urology, Canisius Wilhelmina Hospital (CWZ), Nijmegen, The Netherlands., Los M; Department of Oncology, St. Antonius Hospital, Nieuwegein / Utrecht, The Netherlands., Horenblas S; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek (NCI-AVL) Hospital, Amsterdam, The Netherlands., van Melick HHE; Department of Urology, St. Antonius Hospital, Koekoekslaan 1, 3435 CM, Nieuwegein, The Netherlands.

Publikováno v: World journal of urology [World J Urol] 2022 Jun; Vol. 40 (6), pp. 1469-1479. Date of Electronic Publication: 2022 Apr 10.

Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study.

Autor: Geboers B; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, NSW, Australia; Department of Urology, St. Vincent's Prostate Cancer Research Centre, Darlinghurst, Sydney, NSW, Australia; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers (location VUmc), Free University, Amsterdam, The Netherlands. Electronic address: b.geboers@garvan.org.au., Gondoputro W; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, NSW, Australia; Department of Urology, St. Vincent's Prostate Cancer Research Centre, Darlinghurst, Sydney, NSW, Australia., Thompson JE; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, NSW, Australia; Department of Urology, St. Vincent's Prostate Cancer Research Centre, Darlinghurst, Sydney, NSW, Australia., Reesink DJ; Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands., van Riel LAMJG; Department of Urology, Amsterdam University Medical Centers (location AMC), University of Amsterdam, Amsterdam, The Netherlands; Prostate Cancer Network The Netherlands, Amsterdam, The Netherlands., Zhang D; Department of Urology, E.J. Whitten Prostate Cancer Research Centre at Epworth, Melbourne, VIC, Australia., Blazevski A; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, NSW, Australia; Department of Urology, St. Vincent's Prostate Cancer Research Centre, Darlinghurst, Sydney, NSW, Australia., Doan P; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, NSW, Australia; Department of Urology, St. Vincent's Prostate Cancer Research Centre, Darlinghurst, Sydney, NSW, Australia., Agrawal S; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, NSW, Australia; Department of Urology, St. Vincent's Prostate Cancer Research Centre, Darlinghurst, Sydney, NSW, Australia., Matthews J; Department of Urology, St. Vincent's Prostate Cancer Research Centre, Darlinghurst, Sydney, NSW, Australia., Haynes AM; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, NSW, Australia., Liu Z; Department of Biostatistics, University of New South Wales, NSW, Australia., Delprado W; Douglass Hanly Moir Pathology, Sydney, NSW, Australia., Shnier R; I-MED Radiology, Sydney, NSW, Australia., de Reijke TM; Department of Urology, Amsterdam University Medical Centers (location AMC), University of Amsterdam, Amsterdam, The Netherlands., Lawrentschuk N; Department of Urology, E.J. Whitten Prostate Cancer Research Centre at Epworth, Melbourne, VIC, Australia., Stijns PEF; Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands., Yaxley JW; Department of Urology, The Wesley Hospital, Brisbane, QLD, Australia., Scheltema MJ; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, NSW, Australia; Department of Urology, St. Vincent's Prostate Cancer Research Centre, Darlinghurst, Sydney, NSW, Australia; Department of Urology, Amsterdam University Medical Centers (location AMC), University of Amsterdam, Amsterdam, The Netherlands; Prostate Cancer Network The Netherlands, Amsterdam, The Netherlands., Stricker PD; Department of Urology, St. Vincent's Prostate Cancer Research Centre, Darlinghurst, Sydney, NSW, Australia.

Publikováno v: European urology focus [Eur Urol Focus] 2022 Nov; Vol. 8 (6), pp. 1591-1598. Date of Electronic Publication: 2022 May 14.

Comparison of risk-calculator and MRI and consecutive pathways as upfront stratification for prostate biopsy.

Autor: Reesink DJ; Department of Urology, St. Antonius Hospital Utrecht/Nieuwegein, Koekoekslaan 1, Utrecht, 3435CM, The Netherlands. d.reesink@antoniusziekenhuis.nl., Schilham MGM; Department of Urology, St. Antonius Hospital Utrecht/Nieuwegein, Koekoekslaan 1, Utrecht, 3435CM, The Netherlands., van der Hoeven EJRJ; Department of Radiology, St. Antonius Hospital Utrecht/Nieuwegein, Utrecht, The Netherlands., Schoots IG; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Melick HHE; Department of Urology, St. Antonius Hospital Utrecht/Nieuwegein, Koekoekslaan 1, Utrecht, 3435CM, The Netherlands., van den Bergh RCN; Department of Urology, St. Antonius Hospital Utrecht/Nieuwegein, Koekoekslaan 1, Utrecht, 3435CM, The Netherlands.

Publikováno v: World journal of urology [World J Urol] 2021 Jul; Vol. 39 (7), pp. 2453-2461. Date of Electronic Publication: 2020 Oct 22.

Personalized Treatment Strategy in “Low-Risk Prostate Cancer Active Surveillance Candidates” Using Irreversible Electroporation: Prospective Evaluation of Feasibility, Morbidity, Functional and Oncological Outcomes.

Autor: Popeneciu, Ionel Valentin^1,2, Mohr, Mirjam Naomi¹, Strauß, Arne¹, Leitsmann, Conrad¹, Trojan, Lutz¹, Reichert, Mathias¹ mathias.reichert@med.uni-goettingen.de

Publikováno v: World Journal of Men's Health. Oct2024, Vol. 42 Issue 4, p821-829. 9p.